Correlation Between Dianthus Therapeutics and Painreform

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Painreform at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Painreform into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Painreform, you can compare the effects of market volatilities on Dianthus Therapeutics and Painreform and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Painreform. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Painreform.

Diversification Opportunities for Dianthus Therapeutics and Painreform

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dianthus and Painreform is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Painreform in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Painreform and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Painreform. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Painreform has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Painreform go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Painreform

Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the Painreform. But the stock apears to be less risky and, when comparing its historical volatility, Dianthus Therapeutics is 11.04 times less risky than Painreform. The stock trades about -0.04 of its potential returns per unit of risk. The Painreform is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  504.00  in Painreform on November 2, 2024 and sell it today you would lose (173.00) from holding Painreform or give up 34.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Dianthus Therapeutics  vs.  Painreform

 Performance 
       Timeline  
Dianthus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Painreform 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Painreform are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical and fundamental indicators, Painreform showed solid returns over the last few months and may actually be approaching a breakup point.

Dianthus Therapeutics and Painreform Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dianthus Therapeutics and Painreform

The main advantage of trading using opposite Dianthus Therapeutics and Painreform positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Painreform can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Painreform will offset losses from the drop in Painreform's long position.
The idea behind Dianthus Therapeutics and Painreform pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings